0001609251-20-000003.txt : 20200518 0001609251-20-000003.hdr.sgml : 20200518 20200515193258 ACCESSION NUMBER: 0001609251-20-000003 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200515 EFFECTIVENESS DATE: 20200518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16807 FILM NUMBER: 20887360 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001609251 XXXXXXXX 03-31-2020 03-31-2020 Krensavage Asset Management, LLC

610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020

13F HOLDINGS REPORT 028-16807 N Kelly Ireland 212-518-1970 /s/ Kelly Ireland New York NY 05-14-2020 0 13 310898 false INFORMATION TABLE 2 krensavage_13f_03312020.xml KRENSAVAGE 13F 03312020 ALKERMES PLC COM G01767105 16837 1167631 SH SOLE 1167631 0 0 ALEXION PHARMACEUTICALS INC COM 015351109 41495 462138 SH SOLE 462138 0 0 ANAPTYSBIO INC COM 032724106 6272 443877 SH SOLE 443877 0 0 BIOGEN INC COM 09062X103 35046 110771 SH SOLE 110771 0 0 CHANGE HEALTHCARE INC COM 15912K100 36 3639 SH SOLE 3639 0 0 ENANTA PHARMACEUTICALS INC COM 29251M106 36017 700318 SH SOLE 700318 0 0 GILEAD SCIENCES INC COM 375558103 8803 117755 SH SOLE 117755 0 0 INVACARE CORP COM 461203101 6592 887246 SH SOLE 887246 0 0 MCKESSON CORP COM 58155Q103 29528 218306 SH SOLE 218306 0 0 REGENERON PHARMACEUTICALS COM 75886F107 42392 86817 SH SOLE 86817 0 0 RTI SURGICAL HDS INC COM 74975N105 6887 4027772 SH SOLE 4027772 0 0 TARO PHARMACEUTICAL INDUS COM M8737E108 29821 487275 SH SOLE 487275 0 0 UNITED THERAPEUTICS CORP COM 91307C102 51172 539646 SH SOLE 539646 0 0